FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37644927> ?p ?o ?g. }

• Q37644927 description "article científic" @default.
• Q37644927 description "article scientifique" @default.
• Q37644927 description "articolo scientifico" @default.
• Q37644927 description "artigo científico" @default.
• Q37644927 description "artículu científicu espublizáu en 2016" @default.
• Q37644927 description "bilimsel makale" @default.
• Q37644927 description "scientific article published on 26 July 2016" @default.
• Q37644927 description "vedecký článok" @default.
• Q37644927 description "vetenskaplig artikel" @default.
• Q37644927 description "videnskabelig artikel" @default.
• Q37644927 description "vědecký článek" @default.
• Q37644927 description "wetenschappelijk artikel" @default.
• Q37644927 description "wissenschaftlicher Artikel" @default.
• Q37644927 description "наукова стаття, опублікована в липні 2016" @default.
• Q37644927 description "научни чланак" @default.
• Q37644927 description "مقالة علمية نشرت في 26 يوليو 2016" @default.
• Q37644927 name "miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1." @default.
• Q37644927 name "miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1." @default.
• Q37644927 name "miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1." @default.
• Q37644927 type Item @default.
• Q37644927 label "miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1." @default.
• Q37644927 label "miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1." @default.
• Q37644927 label "miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1." @default.
• Q37644927 prefLabel "miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1." @default.
• Q37644927 prefLabel "miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1." @default.
• Q37644927 prefLabel "miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1." @default.
• Q37644927 P1433 Q37644927-803A1FB8-96FB-4034-A0E5-3AE330F8C027 @default.
• Q37644927 P1476 Q37644927-1AE86C9F-0E46-412B-8F8E-DCFC75585C1C @default.
• Q37644927 P2093 Q37644927-0D937DDB-9BEC-46F5-BB52-D5E11CA3F6DD @default.
• Q37644927 P2093 Q37644927-1339F876-F62D-4EE2-976C-F39D575900CE @default.
• Q37644927 P2093 Q37644927-49168A8A-0FD7-47C9-9510-3B780C9E5E00 @default.
• Q37644927 P2093 Q37644927-6AE4734D-1E9D-4FD7-B0E2-C39C138B8355 @default.
• Q37644927 P2093 Q37644927-73274D8B-B25E-40C3-953A-9C32BB97C0F6 @default.
• Q37644927 P2093 Q37644927-898FF4B6-F5DC-49F2-8561-3CED7DCDDBED @default.
• Q37644927 P2093 Q37644927-9164829F-C14D-47D3-97EE-35E47657F410 @default.
• Q37644927 P2093 Q37644927-CDC3EB3A-EC66-432D-B55D-D6D4B6BC451D @default.
• Q37644927 P2093 Q37644927-EEB9EFF8-1B6A-4D34-BB76-2812BADB0D44 @default.
• Q37644927 P2860 Q37644927-0163D62A-E9DB-4C56-8BBD-FE11F682D5E0 @default.
• Q37644927 P2860 Q37644927-04116F39-74EA-42E5-A46F-F8ADAB51A6EA @default.
• Q37644927 P2860 Q37644927-049FBB4B-DA4B-4948-ADB3-AA57FD5D44EC @default.
• Q37644927 P2860 Q37644927-0A89443F-6CDA-4257-82B1-C3968D440041 @default.
• Q37644927 P2860 Q37644927-23B11661-9B2B-431C-B90C-F8F62A3CE36A @default.
• Q37644927 P2860 Q37644927-26F047AB-DC7F-46D1-9649-CA6A4764E1E0 @default.
• Q37644927 P2860 Q37644927-2D450DA1-7E01-44E0-85E0-8E0D5663A68E @default.
• Q37644927 P2860 Q37644927-3271B0A5-1F49-4309-A11A-1532B7876B9E @default.
• Q37644927 P2860 Q37644927-38588FC9-4CDD-4E56-AE2F-6B1B53910198 @default.
• Q37644927 P2860 Q37644927-557B5D28-3A90-4086-BCFA-B7F329868EAC @default.
• Q37644927 P2860 Q37644927-5B40F8E6-811B-4B9A-AD12-C0EFA257932B @default.
• Q37644927 P2860 Q37644927-6048793A-DCA9-4715-A7CD-FB180EA1918C @default.
• Q37644927 P2860 Q37644927-70E819B4-69B5-4706-9408-E71943BD1D32 @default.
• Q37644927 P2860 Q37644927-746F4F58-5147-4F66-9DC3-8AD3B483C45D @default.
• Q37644927 P2860 Q37644927-7D412364-69EC-470D-BF4D-115C279B38E1 @default.
• Q37644927 P2860 Q37644927-7ECC3442-E644-43E8-9421-C724A7A4D604 @default.
• Q37644927 P2860 Q37644927-8018BCFF-9C0D-4D54-B7C8-ECB2DAD49CE3 @default.
• Q37644927 P2860 Q37644927-8704BF8C-342D-42DF-BD43-0D3F3CDE5638 @default.
• Q37644927 P2860 Q37644927-90225008-F67B-44ED-BE4D-754A96F6104F @default.
• Q37644927 P2860 Q37644927-A7CC0520-AA3F-469A-9D80-BAEBE03BFFA3 @default.
• Q37644927 P2860 Q37644927-AB90B22C-3D13-4BFB-97C2-C653A93581B6 @default.
• Q37644927 P2860 Q37644927-B62233E6-CFBC-4061-9A9B-8794C40638E5 @default.
• Q37644927 P2860 Q37644927-BDC2B210-F072-4A6C-B298-D977F70C0851 @default.
• Q37644927 P2860 Q37644927-C2EDFD03-F40A-4F5A-BE8A-3F1B5B0AA538 @default.
• Q37644927 P2860 Q37644927-C66E5F83-FB77-41A2-8194-2D8064051741 @default.
• Q37644927 P2860 Q37644927-CE21E2F6-B225-4C00-84A4-659BBF53C64F @default.
• Q37644927 P2860 Q37644927-D16AA841-B52A-4E3B-A12F-5091137F990A @default.
• Q37644927 P2860 Q37644927-DA894185-2351-46C9-AD89-B8E7CE097317 @default.
• Q37644927 P2860 Q37644927-E18C438C-4E4B-4A58-A6D8-5021FC888CFB @default.
• Q37644927 P2860 Q37644927-E55C21E6-8220-4D58-8AD4-93331BC582F5 @default.
• Q37644927 P2860 Q37644927-E9B22EFA-168D-4D14-9885-8E4325B88C39 @default.
• Q37644927 P2860 Q37644927-FBA398B2-BE6E-4C42-ABDD-E4554472129E @default.
• Q37644927 P304 Q37644927-1902C7D2-C700-47B9-ACDD-2D644AABADBB @default.
• Q37644927 P31 Q37644927-7BF130E8-7C1E-4B29-A4F3-E36BA65B703E @default.
• Q37644927 P356 Q37644927-A9C46CC9-2847-4815-ABB7-108E0E7CFB52 @default.
• Q37644927 P407 Q37644927-882B3B50-7380-4780-A84E-AB5643335458 @default.
• Q37644927 P433 Q37644927-0BC28521-44D0-4FC9-8A33-6EFBF9410BE2 @default.
• Q37644927 P478 Q37644927-DBA6A02A-856F-456D-AA8D-FBAC55CA0BEC @default.
• Q37644927 P50 Q37644927-314D9713-57B9-4758-8AB5-150EDE6BE00E @default.
• Q37644927 P577 Q37644927-A30A8096-6008-405C-B19D-89A121DC9849 @default.
• Q37644927 P698 Q37644927-46FC878D-8314-4EF7-928A-E7A3ED774EC8 @default.
• Q37644927 P921 Q37644927-04EEC137-61AF-416B-9FE6-5646F1FEB003 @default.
• Q37644927 P921 Q37644927-EF1D05B7-AB07-42D1-A199-3ACF42EE02A0 @default.
• Q37644927 P932 Q37644927-0E8D1480-EAAC-4E91-9A0A-3BBEA91B1710 @default.
• Q37644927 P356 ONCOTARGET.10845 @default.
• Q37644927 P698 27487127 @default.
• Q37644927 P1433 Q1573155 @default.
• Q37644927 P1476 "miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1." @default.
• Q37644927 P2093 "Chenggang Li" @default.
• Q37644927 P2093 "Cunzhi Yu" @default.
• Q37644927 P2093 "Hong Yan" @default.
• Q37644927 P2093 "Jin Ren" @default.
• Q37644927 P2093 "Man Gao" @default.
• Q37644927 P2093 "Mingxia Liu" @default.
• Q37644927 P2093 "Xinming Qi" @default.
• Q37644927 P2093 "Yizheng Wang" @default.
• Q37644927 P2093 "Yongxiang Yin" @default.
• Q37644927 P2860 Q27861070 @default.
• Q37644927 P2860 Q29616803 @default.
• Q37644927 P2860 Q29617702 @default.
• Q37644927 P2860 Q33829462 @default.
• Q37644927 P2860 Q33891809 @default.
• Q37644927 P2860 Q34094556 @default.

• next